Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 154,429 shares at $75.63 ($11.7M) on 2019-03-12, disclosed to the SEC on 2019-03-14.
Open-market sale of $11.7M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.63 | 938 | $71K | 0.6% |
| 2 | $75.63 | 71 | $5K | 0.0% |
| 3 | $75.63 | 1,047 | $79K | 0.7% |
| 4 | $75.63 | 1,618 | $122K | 1.0% |
| 5 | $75.63 | 9,384 | $710K | 6.1% |
| 6 | $75.63 | 61,122 |
| $4.6M |
| 39.5% |
| 7 | $75.40 | 39 | $3K | 0.0% |
| 8 | $75.40 | 1 | $75 | 0.0% |
| 9 | $75.40 | 4 | $302 | 0.0% |
| 10 | $75.40 | 7 | $528 | 0.0% |
| 11 | $75.40 | 247 | $19K | 0.2% |
| 12 | $75.92 | 63,047 | $4.8M | 40.9% |
| 13 | $75.92 | 73 | $6K | 0.0% |
| 14 | $75.92 | 967 | $73K | 0.6% |
| 15 | $75.92 | 1,080 | $82K | 0.7% |
| 16 | $75.92 | 1,668 | $127K | 1.1% |
| 17 | $75.92 | 9,679 | $735K | 6.3% |
| 18 | $76.05 | 3 | $228 | 0.0% |
| 19 | $76.05 | 49 | $4K | 0.0% |
| 20 | $76.05 | 2,832 | $215K | 1.8% |
| 21 | $76.05 | 75 | $6K | 0.0% |
| 22 | $76.05 | 43 | $3K | 0.0% |
| 23 | $76.05 | 435 | $33K | 0.3% |
| Total | $75.78 avg | 154,429 | $11.7M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |